Fundraising Fox

Iter Investments β€” Full Portfolio

26 tracked investments Β· listed companies and verified rows first

aNUma
Apex Labsapexlabs.comin𝕏

APEX Labs is a pharmaceutical company developing, clinically evaluating, and commercializing psilocybin-based therapies for depression and PTSD, with a primary focus on veteran populations.

BiotechDigital HealthMental Health

Awakn Life Sciences

Toronto

Benjamin Sessa(Executive Officer, Director)Shaun McNully(Executive Officer)Anthony Tennyson(Executive Officer, Director)Jonathan Held(Executive Officer, Director)George Scorsis(Director)James Collins(Executive Officer)

Awkn Life Sciences Incawaknlifesciences.cominacquired by Solvonis Therapeutics

BiotechDigital HealthMental Health

Co-investorsJLS

Beckley Psytechbeckleypsytech.com

AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.

BiotechMedical DevicesMental Health

Christian AngermayerSrinivas Rao

Co-investorsFJ LabsLeafy TunnelNoeticRedbus VenturesWhat If Ventures

Beckley Retreatsbeckleyretreats.cominFeb 2026

Beckley Retreats operates research-informed, legal psilocybin retreat programs, combining pre-retreat preparation, guided psilocybin sessions, and post-retreat integration for individuals seeking personal growth and greater connection.

Mental HealthTravel & HospitalityWellness & FitnessFrederick, US

Neil Markey(Executive Officer, Director)AZA Allsop(Head of Research)Rock Feilding-Mellen(Director)

Clairvoyant
Clairvoyantrxclairvoyantrx.com
Fluence
Fluencetrainingfluencetraining.comin

Fluence provides education and professional certification in psychedelic therapy for therapists and mental health professionals, offering courses on molecule-specific treatments (MDMA, psilocybin, ketamine), harm reduction, and integration.

Digital HealthEdTechMental Health

Co-investorsJLS

Freedom Bio
Freedom Biosciencesfreedombio.coin𝕏

Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.

BiotechDigital HealthMental Health

Dr. John Krystal(Co-founder & CEO)inDina Burkitbayeva(Co-founder)in

Co-investorsBeni Venture CapitalLongeVCManta Ray VenturesPsyMed VenturesUnruly CapitalMBX Capital

Interaxonchoosemuse.comin𝕏

Muse is a brain-sensing wearable platform that combines EEG and fNIRS technology to help users improve sleep, manage stress, and enhance cognitive performance through real-time neurofeedback.

AI & Machine LearningConsumerHardwareHealthtechWellness & FitnessToronto

Ariel Garten(Co-founder and Chief Evangelism Officer)Chris Aimone(Co-founder and Chief Innovation Officer)Trevor Coleman(Executive Officer, Director)Derek Luke(Executive Officer)

BoardJason Wong(Director)Sid Paquette(Director)

Co-investorsInnovative Solutions CanadaNew Ground VenturesOMERS Ventures

MAPS
Muse
Nucleuswithnucleus.com

Nucleus is a venture studio that launches, acquires, and partners with brands and technologies focused on mental wellness and the psychedelic medicine industry.

Digital HealthMental HealthWellness & Fitness

Nucleus Holding
Psilerapsilera.comJul 2021

Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.

AI & Machine LearningBiotechDeep TechHealthtechMental HealthTampa, US

Jacqueline Lee Salm(Executive Officer)Jackie von Salm(Co-Founder & Chief Scientific Officer)inChris Witowski(Co-Founder & CEO)Scott Rairigh(EVP, Corporate Development)Magali Haas(Chief Medical Officer)

Co-investorsBonaventure Equity, LLC

Psygenpsygen.cain𝕏

Psygen is a contract development and manufacturing organization (CDMO) producing psychedelic and neuroplastogen active pharmaceutical ingredients such as LSD, MDMA, and psilocybin, and offering CMC services.

BiotechHealthtechMental Health

Co-investorsNoetic

PsyTech
Psytechglobalpsytechglobal.com

Psytech Global publishes psychedelic research articles and magic mushroom strain guides written by a team of physicians and experts.

Media & EntertainmentWellness & Fitness

Quantified Citizenquantifiedcitizen.comin𝕏

Quantified Citizen is a mobile health-studies and lifelog app that lets users track health factors such as anxiety, stress, depression, and sleep quality using scientifically-validated scales, or join research studies on topics like mental health and psychedelic therapy.

Digital HealthHealthtechMental Health

Reset Pharmaresetpharma.comin𝕏Nov 2021

Reset Pharma is a CNS-focused pharmaceutical company developing psilocybin and related psychedelics for the treatment of mental illness in patients with life-threatening diseases.

BiotechDigital HealthHealthtechMental HealthNew York, US

John Andreadis(Executive Officer, Director)Jan-Anders Karlsson(Executive Officer, Director)Philip Taub(Director)Tim Schlidt(Director)

Co-investorsPsyMed Ventures

Sensorium Therapeuticssensorium.bioinJul 2021

Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.

AI & Machine LearningBiotechDigital HealthMedford, US

Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)

BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)

Co-investorsBonaventure Equity, LLCHatteras Venture PartnersMission BiocapitalService Provider CapitalRoute 66 VenturesSante Health Ventures

Tripptripp.comin𝕏

TRIPP provides immersive meditation and mindfulness experiences available through a mobile app and VR headset platform.

AgTechMental HealthWellness & FitnessVenice, US

Nanea Reeves(Executive Officer, Director)inZachary Norman(Executive Officer, Director)Kevin Keeland(Executive Officer)

BoardTim Chang(Director)

Co-investorsBeni Venture CapitalBitkraft Esports VenturesGrit Capital PartnersHartmann CapitalMayfield FundPresence Capital+3 more

Wesana

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.